Head of Contracts & Pricing

Overview

As a member of Takeda Oncology, your work will contribute to our bold, inspiring vision:
We aspire to cure cancer. Here, you’ll build a career grounded in purpose and be empowered to deliver your best. In this highly visible role, the Sr. Director will lead the strategic and analytic aspects of the US Oncology BU’s commercial and government pricing strategy and commercial contracting management, oversee advanced market access analytics, and lead the newly formed health economics function.

The Sr Director will develop the analytic aspects of the US OBU’s commercial and government pricing plan for all in-line and new products and will be charged with taking a strategic portfolio approach to the disciplines. The Sr Director will manage all aspects within the US OBU for pricing, contracting and marketing access analytics, including but not limited to Pricing, Pricing Compliance, Government Price Reporting, Planning, Contract Administration, Rebates, Group Purchasing Organization, Contract modeling and business cases and Contract Systems.

• Guide the evaluation of new pricing and contracting opportunities, determining which possibilities meet the business unit objectives and establishing the appropriate business steps to capitalize on these opportunities.
• Enhance and manage processes across all access contracting decisions and implement procedures to align cross‑functional teams among access, government pricing, legal, marketing and compliance operations.
• Lead Pricing Governance Committee, Contract Assessments, Business Case Modeling and Analysis.
• Lead development and refresh of business rules and playbooks that include appropriate reporting and compliance.
• Chair the Pricing Committee (comprised of senior leadership from sales, patient value & access, marketing, finance and legal) responsible for the pricing and contracting strategy across all US oncology customer segments.
• Identifying information needs and conducting quantitative analysis of pricing and contracting matters; responsible for advanced market analytics and synthesis of information from internal and external sources to develop complex models that compare alternative scenarios, strategies and terms.
• Manage and model GPO and VBA contract business cases and analytics.
• Oversee Gross to Net (GTN) forecast and models and partner with forecasting and finance groups to ensure that price, discounts, rebate calculations and environmental risks are conveyed, understood and incorporated into financial projections for US OBU.
• Lead pricing analytics for in‑line products and apply strategic thinking around pricing to ensure appropriate contracts for all commercial oncology products meet the overall business goals, especially for late‑stage products entering generics territory.
• Own and present recommendations to the US Oncology Leadership Team (US OLT).
• Lead contract development with key payers – HMOs, PBMs, VA, Federal Supply Schedule, Medicaid, Department of Defense – and oncology GPOs, influencing and negotiating across functions while tracking and evaluating contract performance.
• Help set Patient Value and Access office‑based and field team goals and ensure appropriate measures, metrics and reports are in place to track progress; partner with Insights & Analytics and IT to incorporate measures into CRM and reporting tools and oversee report development.
• Train, coach and develop staff in the complex discipline of pricing, contracting and market analytics to ensure adequate commercial expertise.

• Bachelor’s Degree required, MBA preferred.
• 12+ years of relevant experience.
• Ability to analyze situations and data, synthesize and communicate results, and create recommendations and solutions to business problems.
• Experience in the pharmaceutical marketplace and deep expertise in pricing, market and market access nuances of both oral and injectable products and oncology.
• Expert in Government price and Gross to Net calculations, acting as internal consultant to sales, marketing and CFO.
• In‑depth knowledge in obtaining reimbursement with third‑party commercial payers, Medicare Parts D and B, Medicaid, VA/DOD, integrated payer healthcare…